Clinical Trial Update: Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study [Phase 4]

View source ↗

Summary

Phase 4 prospective study assessing efficacy and safety of Salkera Emollient Foam for moderate to severe keratosis pilaris; study terminated with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratosis Pilaris

Drugs mentioned

• Salkera Emollient Foam

Snippet

Sponsor: Wright State University | Conditions: Keratosis Pilaris | Phase 4 | Status: TERMINATED | Results posted: 2022-02-04